期刊文献+

三维动态增强磁共振门静脉成像的技术方法探讨

Discussion on the Technique and Method of Three-dimensional Dynamic Enhanced Magnetic Resonance Portal Vein Imaging
下载PDF
导出
摘要 目的针对磁共振门静脉成像运用三维动态增强的技术方法展开有效的研究分析。方法本次研究的进行时间段为2016年1月至2019年1月,研究对象为来我院进行门静脉及下腔静脉情况的患者240例,对患者展开动态增强磁共振门静脉成像扫描。结果门静脉形态与结构显示为正常的患者例数为165例,所占比率为68.75%;门静脉形态显示为异常的患者例数为75例,所占比率为31.25%,其中显示为肝硬化门静脉高压的患者例数为30例,所占比率为12.50%,显示为肝癌的患者例数为60例,所占比率为25.00%,显示为布加综合征的患者例数为17例,所占比率为7.08%。结论在临床门静脉检查中运用三维动态增强磁共振成像扫描可取得显著的效果,且可以得到清晰的扫描图像。 Objective To study and analyze the three dimensional dynamic enhancement technique for magnetic resonance portal vein imaging.Methods The study was conducted from January 2016 to January 2019.240 patients with portal vein and inferior vena cava were admitted to our hospital,and dynamic enhanced magnetic resonance portal vein imaging was performed.Results There were 165 cases with normal portal vein morphology and structure,accounting for 68.75%;75 cases with abnormal portal vein morphology,accounting for 31.25%.Among them,there were 30 cases with cirrhosis and portal hypertension,accounting for 12.50%,60 cases with hepatocellular carcinoma,accounting for 25.00%,showing Budd-Chiari syndrome.The number of patients was 17,accounting for 7.08%.Conclusion Three-dimensional dynamic enhanced magnetic resonance imaging(MRI)scanning can be used in clinical portal vein examination.
作者 王宇 WANG Yu(Liaoyang Second People's Hospital,Liaoyang 111000,China)
出处 《中国医药指南》 2020年第12期79-80,共2页 Guide of China Medicine
关键词 门静脉成像 磁共振 扫描时间 技术方法 Portal vein imaging Magnetic resonance Scan time Technical approach
  • 相关文献

参考文献12

二级参考文献82

  • 1贺文,于淑霞,何青.多层螺旋CT门静脉造影诊断肝硬化门静脉高压[J].中国医学影像技术,2005,21(1):93-96. 被引量:38
  • 2罗云辉,彭秀斌,毛俊,陈敏,孙放,陈海东,刘玉涛,肖万宏,何虹,龙雪银,林丽娟.多层螺旋CT肝血管成像[J].中国医学影像技术,2006,22(7):1043-1047. 被引量:15
  • 3侯阳,郭启勇,岳勇,郭文力.对比剂注射速率对64层CT冠状静脉成像质量的影响[J].中国医学影像技术,2007,23(12):1805-1808. 被引量:10
  • 4Wang H, Wang XY, Jiang XX, et ah Comparison of diffusion- weighted with T2 weighted Imaging for detection of small hepa tocellular carcinoma in cirrhosis:preliminary quantitative study at 3T[J]. Aead Radiol,2010,17(2) :239-243.
  • 5Schuhmann-Giampieri G, Schmitt-Willich H,Press WR, et al. Pre clinical evaluation of Gd EOB DTPA as a contrast agent in MR imaging of the hepatobiliary system[J]. Radiology, 1992,183 (1) .- 59-64.
  • 6Vogl TJ, Kummel S, Hammerstingl R, et al. Liver tumors: com- parison of MR imaging with Gd-EOB-DTPA and Gd DTPA[J]. Radiology, 1996,200(1) 59-67.
  • 7Hamm B, Staks T, Muhler A, et al. Phase I clinical evaluation of Gd EOB-DTPA as a hepatobiliary MR contrast agent: safety, pharmacokinetics,and MR imaging[J]. Radiology, 1995,195(3) : 785-792.
  • 8Zech CJ, Vos B, Nordell A, et al. Vascular enhancement in early dynamic liver MR imaging in an animal model: comparison of two injection regimen and two different doses Gd EOB DTPA (ga doxetic acid) with standard Gd-DTPA[J]. Invest Radiol,2009,44 (6) :305-310.
  • 9Kuhn JP, Hegenscheid K, Siegmund W, et al. Normal dynamic MRI enhancement patterns of the upper abdominal organs: ga doxetic compared with gadobutrol[J]. AJR, 2009, 193(5): 1318 1323.
  • 10Zizka J, Klzo L, Ferda J, et al. Dynamic and delayed contrast en- hancement in upper abdominal MRI studies: comparison of gado- xelic acid and gadobutrol[J]. Eur J Radiol,2007,62(2) : 186 191.

共引文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部